EFFECTS OF ANTIPSYCHOTICS ON COGNITIVE-BEHAVIOR IN RATS USING THE DELAYED NON-MATCH TO POSITION PARADIGM

被引:70
作者
DIDRIKSEN, M [1 ]
机构
[1] ST HANS HOSP, INST BIOL PSYCHIAT, DEPT PSYCHOPHARMACOL, DK-4000 ROSKILDE, DENMARK
关键词
ANTIPSYCHOTIC; COGNITION; DELAY NON-MATCH TO POSITION; (RAT);
D O I
10.1016/0014-2999(95)00242-D
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The acute effects of the dopamine D-1 receptor antagonist SCH 23390 [(R)-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol] hemimaleat, the dopamine D-2 receptor antagonists raclopride and haloperidol, the compounds with mixed receptor profiles clozapine, risperidone and sertindole, the alpha(1)-adrenoceptor antagonist prazosin and scopolamine were investigated in a delay-response task, a test for working memory, for rats. SCH 23390 induced a delay-dependent impairment of the performance. Raclopride, haloperidol, clozapine, and risperidone induced a delay-independent impairment. Sertindole was without effect. The specific (delay-dependent) and unspecific (delay-independent) effects on working memory of the dopamine D-1 and D-2 receptor antagonists, respectively, were associated with the dominance of dopamine D-1 receptors in the prefrontal cortex and of dopamine D-2 receptors in the basal structures of the brain. Prazosin did not affect working memory; however, a reduction in intertrial responses was found. Scopolamine induced a delay-independent impairment. It is concluded that the compounds have different activity profiles in this cognitive task. This finding may have important implications for the development of antipsychotics with a lower propensity for cognitive side effects.
引用
收藏
页码:241 / 250
页数:10
相关论文
共 28 条
[1]   COGNITIVE-FUNCTIONING AND POSITIVE AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA [J].
ADDINGTON, J ;
ADDINGTON, D ;
MATICKATYNDALE, E .
SCHIZOPHRENIA RESEARCH, 1991, 5 (02) :123-134
[2]   SERTINDOLE AND SEVERAL ANTIPSYCHOTIC-DRUGS DIFFERENTIALLY INHIBIT THE DISCRIMINATIVE STIMULUS EFFECTS OF AMPHETAMINE, LSD AND ST-587 IN RATS [J].
ARNT, J .
BEHAVIOURAL PHARMACOLOGY, 1992, 3 (01) :11-18
[3]  
BOYSON SJ, 1986, J NEUROSCI, V6, P3177
[4]  
BRAFF DL, 1989, AM J PSYCHIAT, V146, P1006
[5]   DYSFUNCTION IN A PREFRONTAL SUBSTRATE OF SUSTAINED ATTENTION IN SCHIZOPHRENIA [J].
COHEN, RM ;
SEMPLE, WE ;
GROSS, M ;
NORDAHL, TE ;
DELISI, LE ;
HOLCOMB, HH ;
KING, AC ;
MORIHISA, JM ;
PICKAR, D .
LIFE SCIENCES, 1987, 40 (20) :2031-2039
[6]  
DANIEL DG, 1991, J NEUROSCI, V11, P1907
[7]   EXPLORING THE FUNCTIONAL-ROLE OF MONOAMINERGIC NEUROTRANSMISSION - A METHOD FOR EXPLORING NEUROTRANSMITTER DYSFUNCTION IN PSYCHIATRIC-DISORDERS [J].
DOLAN, RJ ;
GRASBY, PM .
BRITISH JOURNAL OF PSYCHIATRY, 1994, 164 :575-580
[8]  
DUNNETT SB, 1988, PSYCHOPHARMACOLOGY, V96, P174
[9]  
ETHERINGTON R, 1987, NEUROSCI RES COMMUN, V1, P135
[10]   D1-DOPAMINE AND D2-DOPAMINE RECEPTOR OCCUPANCY DURING TREATMENT WITH CONVENTIONAL AND ATYPICAL NEUROLEPTICS [J].
FARDE, L ;
WIESEL, FA ;
NORDSTROM, AL ;
SEDVALL, G .
PSYCHOPHARMACOLOGY, 1989, 99 :S28-S31